Article
Association of lipid-lowering drugs with COVID-19 outcomes: A Mendelian Randomization study
2021-07-24
Abstract excerpt
<h4>Background</h4> Lipid metabolism plays an important role in viral infections. Large cohort study suggested a protective potential of lipid-lowering drugs in COVID-19 outcomes, but the nature of observational study precludes it to draw a causal inference. <h4>Objectives</h4> To assess the causal effect of lipid-lowering drugs (HMGCR inhibitors, PCSK9 inhibitors and NPC1L1 inhibitors) on COVID-19 outcomes usin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dfdc859a-be35-56eb-a0d2-b96744283a78
- DOI
- 10.1101/2021.07.20.21260813
